TRVHX
Price
$18.13
Change
+$0.06 (+0.33%)
Updated
Jul 16 closing price
Net Assets
1.64B
VMVIX
Price
$65.16
Change
+$0.31 (+0.48%)
Updated
Jul 16 closing price
Net Assets
30.57B
Interact to see
Advertisement

TRVHX vs VMVIX

Header iconTRVHX vs VMVIX Comparison
Open Charts TRVHX vs VMVIXBanner chart's image
Nuveen Mid Cap Value I
Price$18.13
Change+$0.06 (+0.33%)
VolumeN/A
Net Assets1.64B
Vanguard Mid-Cap Value Index Investor
Price$65.16
Change+$0.31 (+0.48%)
VolumeN/A
Net Assets30.57B
TRVHX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TRVHX vs. VMVIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRVHX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. TRVHX (1.64B). VMVIX pays higher dividends than TRVHX: VMVIX (2.14) vs TRVHX (1.60). TRVHX was incepted earlier than VMVIX: TRVHX (10 years) vs VMVIX (19 years). TRVHX (0.58) is less costly to investors than VMVIX (0.19). TRVHX is a more actively managed with annual turnover of: 48.00 vs. VMVIX (19.00). VMVIX has a lower initial minimum investment than TRVHX: VMVIX (3000) vs TRVHX (100000). VMVIX annual gain was more profitable for investors over the last year : 4.51 vs. TRVHX (-1.84). VMVIX return over 5 years is better than : 66.84 vs. TRVHX (36.02).
TRVHXVMVIXTRVHX / VMVIX
Total Expense Ratio0.580.19305%
Annual Report Gross Expense Ratio0.580.19305%
Fund Existence10 years19 years-
Gain YTD2.4961.893132%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B30.6B5%
Annual Yield % from dividends1.602.1475%
Returns for 1 year-1.844.51-41%
Returns for 3 years14.0526.9852%
Returns for 5 years36.0266.8454%
Returns for 10 yearsN/A84.01-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX23.650.69
+3.01%
Inhibrx Biosciences Inc.
ALGS8.680.18
+2.12%
Aligos Therapeutics Inc
OCSL14.610.16
+1.11%
Oaktree Specialty Lending Corp
WTFCM25.00N/A
N/A
Wintrust Financial Corp
CMA61.14-0.09
-0.15%
Comerica